跳至主要内容
临床试验/NCT01790633
NCT01790633已完成不适用

Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests As a Tool for Screening and Access to Care Among At-Risk Populations

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba2 个研究点 分布在 1 个国家目标入组 327 人开始时间: 2013年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
327
试验地点
2
主要终点
Accessibility of Testing Results

研究概览

简要总结

This is a pilot, monocentric, prospective, randomized control trial looking at the use of rapid tests as a part of normal care. The investigators will be testing for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). Testing will be proposed to all persons seeking care at the Centre d'Accueil, de Soins et d'Orientation from the organization Médecin du Monde (CASO, MDM).

Infection status of participants will be determined by either the standard test (ELISA) or rapid test. The choice between tests will be determined randomly.

The overall goal is to determine the general acceptability and feasibility of rapid tests and to see if they can help individuals increase their awareness of infection status when compared to longer, routine methods of testing. In addition, results from these tests will allow the medical doctor to guide participants to appropriate care. All positive tests will be confirmed at a specialized hospital (Hôptial Saint-Antoine, Paris, France) and health-specific information will be obtained four months after testing.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Screening
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years of age
  • Seeking care at the CASO MDM health care center
  • Accept to be followed at Saint-Antoine Hospital in the event of a positive test.

排除标准

  • Currently under physician's care for viral hepatitis (HBV/HCV-specific) or HIV
  • Already has been tested (must give any of the following as evidence):
  • results from HBV and HCV and HIV tests dating at least 3 months back
  • results from HCV and HIV tests dating at least 3 months back and HBV serology indicating that the participant is immunized against HBV.

结局指标

主要结局

Accessibility of Testing Results

时间窗: Evaluated once, up to 4 months after testing

The number of individuals who obtained test results for HBV, HCV, and/or HIV divided by the total number of tested individuals.

次要结局

  • Access to Care(Evaluated once, up to 4 months after testing)

研究者

发起方
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验